查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1813299

生醫材料市場預測（至 2032 年）：按類型、應用和地區分類的全球分析

Biomaterials Market Forecasts to 2032 - Global Analysis By Type (Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, Natural Biomaterials and Other Types), Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球生醫材料市場預計在 2025 年達到 494 億美元，到 2032 年將達到 920.6 億美元，預測期內的複合年成長率為 9.3%。

生醫材料是天然或合成材料，旨在與生物系統相互作用，用於醫療或治療目的。它們包括金屬、陶瓷、聚合物和複合材料，經過精心設計，用於修復、替換或增強組織和器官功能。生醫材料用於植入、矯正器具、藥物傳遞系統和組織工程等應用，必須具備生物相容性、耐久性和功能性，且不會引發不良免疫反應。其設計通常融合了生物學、化學、材料科學和工程學，以滿足特定的臨床需求。生醫材料將技術與生物學緊密結合，在推動現代醫療保健、再生醫學和生物醫學創新方面發揮關鍵作用。

慢性病和心血管疾病盛行率上升

全球預期壽命的延長以及與生活方式相關的健康問題持續推動對先進生醫材料的需求。再生療法和外科手術極大地受益於這些材料的兼容性和性能。微創手術進一步推動了其在臨床環境中的應用。不斷成長的醫療保健需求強化了生醫材料的戰略重要性。這些不斷發展的醫療需求決定了長期的市場成長。

嚴格的法規和臨床核准流程

醫療級材料必須符合嚴格的安全和性能標準。核准週期長且因司法管轄區而異，增加了合規成本。這些挑戰阻礙了創新並延遲了商業化。中小企業可能難以滿足這些要求。監管碎片化持續限制市場的快速擴張。

植入式醫療設備的普及率不斷提高

與人體組織的整合需要具有高生物相容性和結構可靠性的生醫材料。其應用範圍廣泛，包括整形外科植入、心血管支架、牙科修復體、神經假體介面。材料工程的持續進步正在提升材料的耐用性、功能性和患者療效。全球醫療保健系統對微創、持久的醫療解決方案偏好日益成長。應用趨勢正在加速生醫材料領域的創新週期。

研發生產成本高

開發安全有效的材料需要在研究、測試和合規方面投入大量資金。生產過程通常專業化且資本密集。規模較小的公司可能難以與現有企業競爭。這些成本壓力減緩了產品和市場的開發。經濟壁壘仍然是成長的持續威脅。

COVID-19的影響：

新冠疫情對生醫材料市場產生了多方面的影響。最初，供應鏈中斷、製造業停滯以及選擇性醫療程序的減少阻礙了需求。醫院優先考慮緊急護理，並推遲了包括植入和義肢在內的手術。然而，疫情加速了生醫材料在醫療設備、診斷設備和個人防護設備的應用。醫療基礎設施和研究投資的增加進一步支持了市場復甦。疫情過後，人們對先進醫療解決方案和再生醫學的關注度不斷提高，刺激了對生醫材料的需求。

預計聚合物生醫材料領域將成為預測期內最大的領域

預計聚合物生醫材料領域將在預測期內佔據最大的市場佔有率，這得益於其適應性強、臨床效用範圍廣泛。這些材料廣泛應用於心血管、整形外科和傷口護理領域。其柔韌性、生物相容性和易於自訂的特性使其成為滿足各種醫療需求的理想選擇。可生物分解和藥物釋放聚合物的創新正在拓展其應用範圍。它們還支持微創治療。預計該領域將繼續在產量和創新方面保持領先地位。

預計預測期內眼科領域將以最高的複合年成長率成長。

預計眼科領域將在預測期內實現最高成長率，刺激精準眼部護理解決方案的需求。生醫材料用於人工水晶體、角膜支架和眼部給藥系統。人口老化和視障患者數量的增加推動了生物材料的應用。透明且生物相容性的材料正在改善手術效果。微創眼科手術在全球越來越受歡迎。預計未來幾年該領域將迅速擴張。

比最大的地區

在預測期內，由於創新醫療技術的高採用率和強大的研發活動，預計北美將佔據最大的市場佔有率。生醫材料在該地區廣泛應用於整形外科、心血管設備、創傷治療和整容手術。大學、研究機構和生物技術公司之間的策略聯盟正在推動技術創新和產品開發。成熟的行業參與者、有利的監管政策以及對微創治療日益成長的偏好共同推動著市場擴張。個人化醫療和再生醫學意識的不斷提高也增強了市場前景。

複合年成長率最高的地區：

在預測期內，由於快速的都市化、醫療基礎設施的擴張以及對先進醫療技術的投資不斷增加，預計亞太地區將呈現最高的複合年成長率。慢性病盛行率的上升以及對整形外科、心血管和牙科植入需求的不斷成長，進一步推動了市場成長。中國、印度和日本等國家因其龐大的患者群體和更便利的醫療服務而發揮關鍵作用。此外，政府推動生醫材料研究和本地生產的舉措正在刺激技術創新，使該地區成為未來市場擴張和發展的熱點。

免費客製化服務

此報告的訂閱者可以使用以下免費自訂選項之一：

  • 公司簡介
    • 全面分析其他市場參與者（最多 3 家公司）
    • 主要企業的SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家進行的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 次級研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 抑制因素
  • 機會
  • 威脅
  • 應用分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球生醫材料市場類型

  • 金屬生醫材料
    • 不銹鋼
    • 鈦及鈦合金
    • 鈷鉻合金
  • 聚合物生醫材料
    • 聚甲基丙烯酸甲酯（PMMA）
    • 聚乙烯（PE）
    • 聚丙烯（PP）
    • 聚氯乙烯（PVC）
    • 矽酮
  • 陶瓷生醫材料
    • 氧化鋁
    • 氧化鋯
    • 磷酸鈣
  • 天然生醫材料
    • 膠原蛋白
    • 明膠
    • 幾丁聚醣
    • 藻酸鹽
    • 絲綢
    • 玻尿酸
  • 其他類型

6. 全球生醫材料市場（按應用）

  • 心血管系統
    • 支架和移植物
    • 心臟瓣膜
    • 心律調節器和植入式裝置
  • 整形外科
    • 關節重建
    • 接骨板和螺絲
    • 脊椎移植
  • 眼科
    • 隱形眼鏡
    • 人工水晶體
    • 角膜植入
  • 牙科
    • 人工植牙
    • 牙冠和牙橋
    • 假牙
  • 傷口癒合
    • 手術縫合線
    • 組織密封膠和黏合劑
    • 敷料
  • 神經病學
    • 神經植入
    • 分流
    • 電極
  • 其他應用

7. 全球生醫材料市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第8章：主要進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第9章：企業概況

  • BASF SE
  • Evonik Industries AG
  • Corbion NV
  • Covestro AG
  • Celanese Corporation
  • Carpenter Technology Corporation
  • Victrex plc
  • Zimmer Biomet
  • Johnson & Johnson
  • Medtronic plc
  • Stryker Corporation
  • DSM-Firmenich
  • Noble Biomaterials Inc.
  • CoorsTek Inc.
  • CeramTec GmbH
Product Code: SMRC30760

According to Stratistics MRC, the Global Biomaterials Market is accounted for $49.40 billion in 2025 and is expected to reach $92.06 billion by 2032 growing at a CAGR of 9.3% during the forecast period. Biomaterials are natural or synthetic substances designed to interact with biological systems for medical or therapeutic purposes. They can be metals, ceramics, polymers, or composites, carefully engineered to restore, replace, or enhance the function of tissues and organs. Used in applications such as implants, prosthetics, drug delivery systems, and tissue engineering, biomaterials must exhibit biocompatibility, durability, and functionality without causing adverse immune responses. Their design often integrates biology, chemistry, materials science, and engineering to meet specific clinical needs. By bridging technology and biology, biomaterials play a crucial role in advancing modern healthcare, regenerative medicine, and biomedical innovation.

Market Dynamics:

Driver:

Rising prevalence of chronic and cardiovascular diseases

Rising global life expectancy and lifestyle-induced health issues continue to elevate demand for advanced biomaterials. Regenerative therapies and surgical applications benefit significantly from these materials' compatibility and performance. Minimally invasive procedures further drive utilization across clinical settings. Expanding healthcare needs are reinforcing the strategic importance of biomaterials. Long-term market growth is being shaped by these evolving medical requirements.

Restraint:

Stringent regulatory and clinical approval processes

Medical-grade materials must meet rigorous safety and performance standards. Approval cycles are lengthy and vary across jurisdictions, increasing compliance costs. These challenges slow down innovation and delay commercialization. Smaller firms may find it difficult to navigate these requirements. Regulatory fragmentation continues to restrict rapid market expansion.

Opportunity:

Growing adoption of implantable medical devices

Integration with human tissue demands biomaterials that exhibit high biocompatibility and structural reliability. Applications span orthopedic implants, cardiovascular stents, dental restorations, and neuroprosthetic interfaces. Continuous advancements in material engineering are enhancing durability, functionality, and patient outcomes. Preference for minimally invasive and long-lasting medical solutions is rising across global healthcare systems. Adoption trends are accelerating innovation cycles within the biomaterials sector.

Threat:

High R&D and production costs

Developing safe and effective materials requires substantial investment in research, testing, and regulatory compliance. Production processes are often specialized and capital-intensive. Smaller players may struggle to compete with established firms. These cost pressures slow product development and market penetration. Economic barriers remain a persistent threat to growth.

Covid-19 Impact:

The Covid-19 pandemic had a mixed impact on the biomaterials market. Initially, disruptions in supply chains, manufacturing slowdowns, and reduced elective medical procedures hindered demand. Hospitals prioritized emergency care, delaying surgeries involving implants and prosthetics. However, the pandemic also accelerated the use of biomaterials in medical devices, diagnostics, and personal protective equipment. Increased investments in healthcare infrastructure and research further supported market recovery. Post-pandemic, rising focus on advanced healthcare solutions and regenerative medicine boosted demand for biomaterials.

The polymeric biomaterials segment is expected to be the largest during the forecast period

The polymeric biomaterials segment is expected to account for the largest market share during the forecast period due to their adaptability and broad clinical utility. These materials are widely used in cardiovascular, orthopedic, and wound care applications. Their flexibility, biocompatibility, and ease of customization make them ideal for diverse medical needs. Innovations in biodegradable and drug-releasing polymers are expanding their scope. They also support minimally invasive treatment approaches. This segment will continue to lead in both volume and innovation.

The ophthalmology segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the ophthalmology segment is predicted to witness the highest growth rate increasing demand for precision eye care solutions. Biomaterials are being used in intraocular lenses, corneal scaffolds, and ocular drug delivery systems. Aging populations and rising cases of vision impairment are fuelling adoption. Transparent and biocompatible materials are improving surgical outcomes. Minimally invasive ophthalmic procedures are gaining traction globally. This segment is poised for rapid expansion in the coming years.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share by high adoption of innovative medical technologies, and strong research and development activities. The region shows widespread use of biomaterials in orthopedics, cardiovascular devices, wound healing, and cosmetic surgery. Strategic collaborations between universities, research institutions, and biotech firms foster innovation and product development. Established industry players, favorable regulatory policies, and the rising preference for minimally invasive treatments collectively fuel market expansion. Growing awareness about personalized healthcare and regenerative medicine also strengthens the market landscape.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR by rapid urbanization, an expanding healthcare infrastructure, and growing investments in advanced medical technologies. Increasing prevalence of chronic diseases and rising demand for orthopedic, cardiovascular, and dental implants further support market growth. Countries such as China, India, and Japan play a significant role due to large patient populations and improving healthcare access. Additionally, government initiatives promoting research and local production of biomaterials encourage innovation, making the region a hotspot for future market expansion and development.

Key players in the market

Some of the key players in Biomaterials Market include BASF SE, Evonik Industries AG, Corbion N.V., Covestro AG, Celanese Corporation, Carpenter Technology Corporation, Victrex plc, Zimmer Biomet, Johnson & Johnson, Medtronic plc, Stryker Corporation, DSM-Firmenich, Noble Biomaterials Inc., CoorsTek Inc. and CeramTec GmbH.

Key Developments:

In July 2025, BASF signed a global framework agreement with CATL to supply advanced cathode active materials for lithium-ion batteries. While focused on energy storage, the partnership leverages BASF's biomaterials expertise in sustainable sourcing and circular chemistry to support CATL's green transformation goals.

In January 2025, Evonik formed a joint venture with Fuhua Tongda Chemical Co., Ltd. in Sichuan, China, to produce specialty hydrogen peroxide for medical and semiconductor applications. The venture builds on a prior licensing agreement and supports Evonik's biomaterials strategy by securing sustainable raw materials for high-purity processing.

Types Covered:

  • Metallic Biomaterials
  • Polymeric Biomaterials
  • Ceramic Biomaterials
  • Natural Biomaterials
  • Other Types

Applications Covered:

  • Cardiovascular
  • Orthopedic
  • Ophthalmology
  • Dental
  • Wound Healing
  • Wound Healing
  • Neurology
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Biomaterials Market, By Type

  • 5.1 Introduction
  • 5.2 Metallic Biomaterials
    • 5.2.1 Stainless Steel
    • 5.2.2 Titanium & Titanium Alloys
    • 5.2.3 Cobalt-Chromium Alloys
  • 5.3 Polymeric Biomaterials
    • 5.3.1 Polymethyl Methacrylate (PMMA)
    • 5.3.2 Polyethylene (PE)
    • 5.3.3 Polypropylene (PP)
    • 5.3.4 Polyvinyl Chloride (PVC)
    • 5.3.5 Silicone
  • 5.4 Ceramic Biomaterials
    • 5.4.1 Alumina
    • 5.4.2 Zirconia
    • 5.4.3 Calcium Phosphates
  • 5.5 Natural Biomaterials
    • 5.5.1 Collagen
    • 5.5.2 Gelatin
    • 5.5.3 Chitosan
    • 5.5.4 Alginate
    • 5.5.5 Silk
    • 5.5.6 Hyaluronic Acid
  • 5.6 Other Types

6 Global Biomaterials Market, By Application

  • 6.1 Introduction
  • 6.2 Cardiovascular
    • 6.2.1 Stents & Grafts
    • 6.2.2 Heart Valves
    • 6.2.3 Pacemakers & Implantable Devices
  • 6.3 Orthopedic
    • 6.3.1 Joint Replacement
    • 6.3.2 Bone Plates & Screws
    • 6.3.3 Spinal Implants
  • 6.4 Ophthalmology
    • 6.4.1 Contact Lenses
    • 6.4.2 Intraocular Lenses
    • 6.4.3 Corneal Implants
  • 6.5 Dental
    • 6.5.1 Dental Implants
    • 6.5.2 Crowns & Bridges
    • 6.5.3 Dentures
  • 6.6 Wound Healing
    • 6.6.1 Surgical Sutures
    • 6.6.2 Tissue Sealants & Adhesives
    • 6.6.3 Dressings
  • 6.7 Neurology
    • 6.7.1 Neural Implants
    • 6.7.2 Shunts
    • 6.7.3 Electrodes
  • 6.8 Other Applications

7 Global Biomaterials Market, By Geography

  • 7.1 Introduction
  • 7.2 North America
    • 7.2.1 US
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 Italy
    • 7.3.4 France
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 New Zealand
    • 7.4.6 South Korea
    • 7.4.7 Rest of Asia Pacific
  • 7.5 South America
    • 7.5.1 Argentina
    • 7.5.2 Brazil
    • 7.5.3 Chile
    • 7.5.4 Rest of South America
  • 7.6 Middle East & Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 Qatar
    • 7.6.4 South Africa
    • 7.6.5 Rest of Middle East & Africa

8 Key Developments

  • 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 8.2 Acquisitions & Mergers
  • 8.3 New Product Launch
  • 8.4 Expansions
  • 8.5 Other Key Strategies

9 Company Profiling

  • 9.1 BASF SE
  • 9.2 Evonik Industries AG
  • 9.3 Corbion N.V.
  • 9.4 Covestro AG
  • 9.5 Celanese Corporation
  • 9.6 Carpenter Technology Corporation
  • 9.7 Victrex plc
  • 9.8 Zimmer Biomet
  • 9.9 Johnson & Johnson
  • 9.10 Medtronic plc
  • 9.11 Stryker Corporation
  • 9.12 DSM-Firmenich
  • 9.13 Noble Biomaterials Inc.
  • 9.14 CoorsTek Inc.
  • 9.15 CeramTec GmbH

List of Tables

  • Table 1 Global Biomaterials Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Biomaterials Market Outlook, By Type (2024-2032) ($MN)
  • Table 3 Global Biomaterials Market Outlook, By Metallic Biomaterials (2024-2032) ($MN)
  • Table 4 Global Biomaterials Market Outlook, By Stainless Steel (2024-2032) ($MN)
  • Table 5 Global Biomaterials Market Outlook, By Titanium & Titanium Alloys (2024-2032) ($MN)
  • Table 6 Global Biomaterials Market Outlook, By Cobalt-Chromium Alloys (2024-2032) ($MN)
  • Table 7 Global Biomaterials Market Outlook, By Polymeric Biomaterials (2024-2032) ($MN)
  • Table 8 Global Biomaterials Market Outlook, By Polymethyl Methacrylate (PMMA) (2024-2032) ($MN)
  • Table 9 Global Biomaterials Market Outlook, By Polyethylene (PE) (2024-2032) ($MN)
  • Table 10 Global Biomaterials Market Outlook, By Polypropylene (PP) (2024-2032) ($MN)
  • Table 11 Global Biomaterials Market Outlook, By Polyvinyl Chloride (PVC) (2024-2032) ($MN)
  • Table 12 Global Biomaterials Market Outlook, By Silicone (2024-2032) ($MN)
  • Table 13 Global Biomaterials Market Outlook, By Ceramic Biomaterials (2024-2032) ($MN)
  • Table 14 Global Biomaterials Market Outlook, By Alumina (2024-2032) ($MN)
  • Table 15 Global Biomaterials Market Outlook, By Zirconia (2024-2032) ($MN)
  • Table 16 Global Biomaterials Market Outlook, By Calcium Phosphates (2024-2032) ($MN)
  • Table 17 Global Biomaterials Market Outlook, By Natural Biomaterials (2024-2032) ($MN)
  • Table 18 Global Biomaterials Market Outlook, By Collagen (2024-2032) ($MN)
  • Table 19 Global Biomaterials Market Outlook, By Gelatin (2024-2032) ($MN)
  • Table 20 Global Biomaterials Market Outlook, By Chitosan (2024-2032) ($MN)
  • Table 21 Global Biomaterials Market Outlook, By Alginate (2024-2032) ($MN)
  • Table 22 Global Biomaterials Market Outlook, By Silk (2024-2032) ($MN)
  • Table 23 Global Biomaterials Market Outlook, By Hyaluronic Acid (2024-2032) ($MN)
  • Table 24 Global Biomaterials Market Outlook, By Other Types (2024-2032) ($MN)
  • Table 25 Global Biomaterials Market Outlook, By Application (2024-2032) ($MN)
  • Table 26 Global Biomaterials Market Outlook, By Cardiovascular (2024-2032) ($MN)
  • Table 27 Global Biomaterials Market Outlook, By Stents & Grafts (2024-2032) ($MN)
  • Table 28 Global Biomaterials Market Outlook, By Heart Valves (2024-2032) ($MN)
  • Table 29 Global Biomaterials Market Outlook, By Pacemakers & Implantable Devices (2024-2032) ($MN)
  • Table 30 Global Biomaterials Market Outlook, By Orthopedic (2024-2032) ($MN)
  • Table 31 Global Biomaterials Market Outlook, By Joint Replacement (2024-2032) ($MN)
  • Table 32 Global Biomaterials Market Outlook, By Bone Plates & Screws (2024-2032) ($MN)
  • Table 33 Global Biomaterials Market Outlook, By Spinal Implants (2024-2032) ($MN)
  • Table 34 Global Biomaterials Market Outlook, By Ophthalmology (2024-2032) ($MN)
  • Table 35 Global Biomaterials Market Outlook, By Contact Lenses (2024-2032) ($MN)
  • Table 36 Global Biomaterials Market Outlook, By Intraocular Lenses (2024-2032) ($MN)
  • Table 37 Global Biomaterials Market Outlook, By Corneal Implants (2024-2032) ($MN)
  • Table 38 Global Biomaterials Market Outlook, By Dental (2024-2032) ($MN)
  • Table 39 Global Biomaterials Market Outlook, By Dental Implants (2024-2032) ($MN)
  • Table 40 Global Biomaterials Market Outlook, By Crowns & Bridges (2024-2032) ($MN)
  • Table 41 Global Biomaterials Market Outlook, By Dentures (2024-2032) ($MN)
  • Table 42 Global Biomaterials Market Outlook, By Wound Healing (2024-2032) ($MN)
  • Table 43 Global Biomaterials Market Outlook, By Surgical Sutures (2024-2032) ($MN)
  • Table 44 Global Biomaterials Market Outlook, By Tissue Sealants & Adhesives (2024-2032) ($MN)
  • Table 45 Global Biomaterials Market Outlook, By Dressings (2024-2032) ($MN)
  • Table 46 Global Biomaterials Market Outlook, By Neurology (2024-2032) ($MN)
  • Table 47 Global Biomaterials Market Outlook, By Neural Implants (2024-2032) ($MN)
  • Table 48 Global Biomaterials Market Outlook, By Shunts (2024-2032) ($MN)
  • Table 49 Global Biomaterials Market Outlook, By Electrodes (2024-2032) ($MN)
  • Table 50 Global Biomaterials Market Outlook, By Other Applications (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.